Stay updated with breaking news from Ancer Prostate . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The addition of PSMA-PET/CT to MRI-target biopsy changed treatment plans for most patients with clinically significant tumors, but some experts note that the cost may outweigh the benefit.
When a 68-year-old man in Norway died of infection after a transrectal biopsy, his daughter urged change. Four years later, that campaign looks to be a success ― but the US has moved slowly to adapt.
A large study from Germany found that digital rectal examination had low detection rates compared with prostate-specific antigen testing in men in their mid-to-late 40s.
Men with newly diagnosed non-metastatic prostate cancer who were randomly assigned to surgery, radiation, or active monitoring had similar overall and prostate cancer-specific survival rates after 15 years.
Incorporating peer coaching from a genetics expert into the community oncology setting helped increase uptake of germline genetic testing among eligible patients.